首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到20条相似文献,搜索用时 166 毫秒
1.
以10 mol%(R,R)-环己二胺衍生的手性双功能硫脲叔胺(4b)为催化剂,3'-吲哚-3-氧化吲哚与α-氨基砜为原料,经3'-吲哚-3-氧化吲哚与原位生成的N-Boc芳香醛亚胺的不对称Mannich反应,合成了20个3,3-二取代3-吲哚-3'-基氧化吲哚类化合物(3a~3t),分离收率54%~98%,dr值90∶10~99∶1,其结构经~1H NMR,~(13)C NMR和HR-MS(ESI-TOF)表征。  相似文献   

2.
以取代吲哚为原料,经维尔斯迈尔-哈克反应制得取代吲哚-3-甲醛,再通过DMSO/NaOH体系制得N-取代吲哚-3-甲醛(3a~3g);3a~3g经Na BH4还原合成了7个未见文献报道的取代吲哚-3-甲醇类衍生物(4a~4g),其结构经~1H NMR,~(13)C NMR和MS表征。  相似文献   

3.
固体酸Amberlyst 15催化合成3-吲哚取代的苯酞类化合物   总被引:1,自引:0,他引:1  
林华  韩京成  孙兴文  林国强 《有机化学》2008,28(8):1479-1482
室温下, 以吲哚和邻甲酰苯甲酸为原料, 通过Amberlyst 15 (15 wt%)催化的傅-克反应, 高产率合成得到一系列3-吲哚取代的苯酞类化合物. 并通过1H NMR, 13C NMR, 红外光谱, 高分辨质谱确证了产物的结构.  相似文献   

4.
李小云  郭其祥 《合成化学》2017,25(4):340-343
开发了一种以吲哚为起始原料,合成具有多个反应位点的多取代3-烯基吲哚的新方法,合成了9个目标化合物,其中8个为新化合物,其结构经1H NMR, 13C NMR和HR-MS(ESI)表征。  相似文献   

5.
研究了BINOL酸催化α-羰基二硫缩烯酮的吲哚化反应,合成了12个β-吲哚基-β-乙硫基缩烯酮类化合物(3a~3l),其中3a,3d~3e,3g~3k为新化合物,其结构经~1H NMR,~(13)C NMR,IR和HR-MS表征。对反应条件进行了优化。结果表明:20 mol%BINOL酸为催化剂,3,3-二乙硫基苯丙烯酮与吲哚于85℃反应2.5 h,3-吲哚基-3-乙硫基苯丙烯酮收率85%。  相似文献   

6.
金催化的吲哚与末端炔烃的分子间烷基化反应   总被引:1,自引:0,他引:1  
尝试了用金(Au)催化吲哚和炔烃的Friedel-Crafts烷基化反应, 具体探讨了金(I)配合物催化吲哚与末端炔烃的烷基化反应的条件, 并制备了一系列尚未见文献报道的双取代β-吲哚烷基化衍生物. 产物的结构经1H NMR, 13C NMR, MS和元素分析确证. 并对其反应机理可能性进行了推测.  相似文献   

7.
3,3-二甲基-2-(3-甲基薁乙烯基)-3H-吲哚衍生物的合成   总被引:1,自引:1,他引:0  
1-甲酰基薁-3-甲酸甲酯和2,3,3-三甲基-3H-吲哚衍生物发生缩合反应,合成了一系列3,3-二甲基-2-(3-甲基薁乙烯基)-3H-吲哚衍生物,收率48%~64%,其结构经~1H NMR,IR和元素分析表征.  相似文献   

8.
葛裕华  王绵海 《合成化学》2007,15(4):468-470
以取代苄氧基吲哚-3-甲醛和4-硝基苯肼为原料,乙醇为溶剂,通过缩合脱水反应合成了4个新化合物--取代苄氧基吲哚-3-甲醛-(4'-硝基)苯腙,其结构经1H NMR,IR,MS和元素分析表征.  相似文献   

9.
螺环氧化吲哚和氮杂环丙烷都是非常重要的活性骨架,以3-烯氧化吲哚和双保护的羟胺为起始原料,基于Michael加成-取代串联反应,实现了螺氮杂环丙烷氧化吲哚的不对称合成.通过对一系列手性催化剂、反应温度等的筛选,最终确定了奎宁和辛克宁为最优催化剂,分别以28%和34%的对映选择性得到目标产物,其结构经过1~H NMR、~(13)C NMR和HRMS确定.  相似文献   

10.
张颜萍  游勇  袁伟成 《合成化学》2019,27(12):930-934
探究了Sc(OTf)3催化的吲哚与(E)-4,4,4-三氟-1-(2′-吡啶基)丁-2-烯-1-酮的傅克反应。考察了催化剂和溶剂对反应收率的影响,以95%~99%的收率得到一系列含有三氟甲基的吲哚类化合物,其结构经1H NMR、 13C NMR和HR-MS(ESI-TOF)确认。  相似文献   

11.
Three new lignan glycosides (1-3) were isolated from the stems of Akebia trifoliata. Their structures were elucidated as (7R,8R,7'R,8'R)3,3',5,5'tetramethoxy-4,4'dihydroxy-7,9':7',9-diepoxylignan-4-O-beta-D-glucopyranoside (1), (7S,8S,8'R)-4,4',9-trihydroxy-3,3',5,5'-tetramethoxy-7,9'-epoxylignan-7'-one 9-O-beta-D-glucopyranoside (2), (7R,8R,8'S)-4,4',9-trihydroxy3,3',5,5'-tetramethoxy-7,9'-epoxylignan-7'-one 9-O-beta-D-glucopyranoside (3) by spectral analyses, primarily NMR, MS and CD. The NMR assignments for the compounds were carried out using 1H, 13C, DEPT, COSY, HSQC, HMBC and ROESY NMR experiments.  相似文献   

12.
A series of 12 1-{4-[3-(9H-carbazol-4-yloxy)-2-hydroxy-propylamino]-phenyl}-3-(substituted aryl)-propenone were synthesized using 4-(oxiran-2-ylmethoxy)-9H-carbazole and p-amino acetophenone as starting materials. Synthesis of chalcone was by base catalyst. They were characterized using FTIR, 1H NMR, 13C NMR, and spectroscopy analysis.  相似文献   

13.
赤霉素(Gibberellins)是一类重要的具有多种生理活性的植物生长刺激素,在农业、植物生理学、园艺学及医学等方面有广泛的用途。某些2,2-二烷基赤霉素衍生物具有很强的生理活性,如2,2-二甲基赤霉素A_4(1)的生理活性是赤霉酸GA_3(3)的50倍。为了深入探讨这类化合物的生理活性及其构效关系,合成一系列新的2,2-二烷基赤霉素衍生物是一项有意义的工作。Beale M.H等通过微生物法将1转化成为2,2-二甲基赤霉素A_1(2),但收率低,后处理烦琐。有关2的化学合成尚未见报道。 本文以赤霉酸GA_3(3)为原料,通过6步化学反应,成功地合成了2,2-二甲基赤霉素A_1甲酯(9_a)及其差向异构体2,2-二甲基表赤霉素A_1甲酯(9_b)。具体合成路线如下:  相似文献   

14.
Four new 8-O-4' type neolignan glycosides with enantiometric aglycones, (7S,8R)-erythro-guaiacylglycerol-beta-O-4'-sinapyl ether 9-O-beta-D-glucopyranoside (1), (7R,8S)-erythro-guaiacylglycerol-beta-O-4'-sinapyl ether 9-O-beta-D-glucopyranoside (2), (7S,8R)-erythro- syringylglycerol-beta-O-4'-sinapyl ether 9-O-beta-D-glucopyranoside (3) and (7R,8S)-erythro- syringylglycerol-beta-O-4'-sinapyl ether 9-O-beta-D-glucopyranoside (4), were isolated from the leaves of Osmanthus ilicifolius. Their structures were established on the basis of NMR, circular dichroism (CD), MS and chemical data. The NMR assignments for the compounds were carried out using (1)H, (13)C, COSY, HMQC, HMBC and NOESY NMR experiments.  相似文献   

15.
以系列羟基卟啉为原料,用对甲苯磺酰肼还原,再用四氯对苯醌氧化,制得二氢卟吩(2a~2d);以二环己基碳二亚胺为脱水剂,2与5-氟尿嘧啶-1-基乙酸经酯化反应合成了4个新型二氢卟吩-5-氟尿嘧啶化合物(3a~3d),总收率分别为6.9%, 6.9%, 7.0%和7.6%,其结构经UV-Vis, 1H NMR, IR和MS表征。  相似文献   

16.
以腺苷为母体,对其N6-位进行结构改造,首先经邻位双羟基保护,N6-位氯代,再在N6-位引入哌嗪环制得中间体2',3'-异丙叉-6-哌嗪嘌呤核苷(4);4与N-氯乙酰苯胺类似物(6a~6h)偶联后脱除邻位双羟基保护合成了8个新型的N6-哌嗪取代腺苷衍生物(8a~8h),其结构经1H NMR,13C NMR和HR-ESI-MS表征。采用MTT法研究了8a~8h对Hela肿瘤细胞的抑制活性。结果表明:大部分目标化合物对Hela肿瘤细胞具有较好的抑制活性,其中2-{4-[9-(3,4-二羟基-5-羟甲基-四氢呋喃-2-基)-9H-嘌呤-6-基]-哌嗪-1-基}-N-(3-氟苯基)-乙酰胺(8e)的活性最好,IC50为21.74μmol·L-1。  相似文献   

17.
Vícha J  Demo G  Marek R 《Inorganic chemistry》2012,51(3):1371-1379
Two novel Pt(IV) complexes of aromatic cytokinins with possible antitumor properties were prepared by reaction of selected aminopurines with K(2)PtCl(6). The structures of both complexes, 9-[6-(benzylamino)purine] pentachloroplatinate (IV) and 9-[6-(furfurylamino)purine] pentachloroplatinate (IV), were characterized in detail by using two-dimensional NMR spectroscopy ((1)H, (13)C, (15)N, and (195)Pt) in solution and CP/MAS NMR techniques in the solid state. We report for the first time the X-ray structure of a nucleobase adenine derivative coordinated to Pt(IV) via the N9 atom. The protonation equilibria for the complexes in solution were characterized by using NMR spectroscopy (isotropic chemical shifts and indirect nuclear spin-spin coupling constants) and the structural conclusions drawn from the NMR analysis are supported by relativistic density-functional theory (DFT) calculations. Because of the presence of the Pt atom, hybrid GGA functionals and scalar-relativistic and spin-orbit corrections were employed for both the DFT calculations of the molecular structure and particularly for the NMR chemical shifts. In particular, the populations of the N7-protonated and neutral forms of the complexes in solution were characterized by correlating the experimental and the DFT-calculated NMR chemical shifts. In contrast to the chemical exchange process involving the N7-H group, the hydrogen atom at N3 was determined to be unexpectedly rigid, probably because of the presence of the stabilizing intramolecular interaction N3-H···Cl. The described methodology combining the NMR spectroscopy and relativistic DFT calculations can be employed for characterizing the tautomeric and protonation equilibria in a large family of transition-metal-modified purine bases.  相似文献   

18.
The 1H and 13C NMR data for 3-azabicyclo[3.3.1]nonanes with OH and OMe substituents at C-6 and C-9 were measured using 1D (DEPT) and 2D (COSY, HSQC, HMBC, NOESY) experiments. Comparison of this NMR data illustrates the effects of stereochemistry and substitution at these positions.  相似文献   

19.
The temperature-dependent (1)H and (13)C NMR spectra of 2-(2-butynyl)-10-methyl-1,2,3,4-tetrahydropyrazino[1,2-a]indole (4) (as a representative example of 1-9) in CFCl(3) + CD(2)Cl(2) solution are described and discussed. Below 183 K, the hexahydropyrazine ring inversions become slow on the NMR time-scale and 4 exists in principle as two conformational diastereomers. In fact, only one was observed with the N-2 substituent in an equatorial position as shown by a low-temperature NOESY experiment. The energy barrier for conformational interchange was calculated from NMR data to be 8.3 kcal mol(-1) (1 kcal = 4.184 kJ), in agreement with quantum chemical calculations. Unambiguous assignments for all proton and carbon resonances of 1-9 were made using 1D (APT, DEPT, NOE difference) and 2D (COSY, NOESY, gHMQC, gHMBC) NMR techniques.  相似文献   

20.
《Tetrahedron: Asymmetry》2005,16(15):2559-2568
Enantioresolution of 3-octanol, 6-methyl-5-hepten-2-ol (sulcatol), and 1-octen-3-ol was conducted using (S)-(+)-2-methoxy-2-(1-naphthyl)propionic acid (MαNP acid) and (S)-(+)-2-methoxy-2-(9-phenanthryl)propionic acid (M9PP acid). In each case, the diastereomeric esters obtained were readily separated by HPLC. The stereochemistry of the esters could be assigned from their respective 1H NMR analyses. Solvolyses of the esters gave enantiopure alcohols and acids. MαNP and M9PP acids displayed almost equivalent properties in 1H NMR anisotropy. The chiral resolving ability of M9PP acid was slightly superior to that of MαNP acid in HPLC.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号